BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15659489)

  • 1. Prediction of docetaxel response in human breast cancer by gene expression profiling.
    Iwao-Koizumi K; Matoba R; Ueno N; Kim SJ; Ando A; Miyoshi Y; Maeda E; Noguchi S; Kato K
    J Clin Oncol; 2005 Jan; 23(3):422-31. PubMed ID: 15659489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer.
    Chang JC; Wooten EC; Tsimelzon A; Hilsenbeck SG; Gutierrez MC; Elledge R; Mohsin S; Osborne CK; Chamness GC; Allred DC; O'Connell P
    Lancet; 2003 Aug; 362(9381):362-9. PubMed ID: 12907009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers.
    Ooe A; Kato K; Noguchi S
    Breast Cancer Res Treat; 2007 Mar; 101(3):305-15. PubMed ID: 16821082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.
    Chang JC; Wooten EC; Tsimelzon A; Hilsenbeck SG; Gutierrez MC; Tham YL; Kalidas M; Elledge R; Mohsin S; Osborne CK; Chamness GC; Allred DC; Lewis MT; Wong H; O'Connell P
    J Clin Oncol; 2005 Feb; 23(6):1169-77. PubMed ID: 15718313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting response to docetaxel neoadjuvant chemotherapy for advanced breast cancers through genome-wide gene expression profiling.
    Zembutsu H; Suzuki Y; Sasaki A; Tsunoda T; Okazaki M; Yoshimoto M; Hasegawa T; Hirata K; Nakamura Y
    Int J Oncol; 2009 Feb; 34(2):361-70. PubMed ID: 19148470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer.
    Kim SJ; Miyoshi Y; Taguchi T; Tamaki Y; Nakamura H; Yodoi J; Kato K; Noguchi S
    Clin Cancer Res; 2005 Dec; 11(23):8425-30. PubMed ID: 16322305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients.
    Chang JC; Makris A; Gutierrez MC; Hilsenbeck SG; Hackett JR; Jeong J; Liu ML; Baker J; Clark-Langone K; Baehner FL; Sexton K; Mohsin S; Gray T; Alvarez L; Chamness GC; Osborne CK; Shak S
    Breast Cancer Res Treat; 2008 Mar; 108(2):233-40. PubMed ID: 17468949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for response to docetaxel in human breast cancers.
    Noguchi S
    Cancer Sci; 2006 Sep; 97(9):813-20. PubMed ID: 16805818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of response to docetaxel by quantitative analysis of class I and III beta-tubulin isotype mRNA expression in human breast cancers.
    Hasegawa S; Miyoshi Y; Egawa C; Ishitobi M; Taguchi T; Tamaki Y; Monden M; Noguchi S
    Clin Cancer Res; 2003 Aug; 9(8):2992-7. PubMed ID: 12912947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells.
    Brown I; Shalli K; McDonald SL; Moir SE; Hutcheon AW; Heys SD; Schofield AC
    Breast Cancer Res; 2004; 6(5):R601-7. PubMed ID: 15318941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of BRCA2 mRNA predicts favorable response to docetaxel in breast cancer.
    Egawa C; Miyoshi Y; Takamura Y; Taguchi T; Tamaki Y; Noguchi S
    Int J Cancer; 2001 Jul; 95(4):255-9. PubMed ID: 11400119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers.
    Tham YL; Gomez LF; Mohsin S; Gutierrez MC; Weiss H; Hilsenbeck SG; Elledge RM; Chamness GC; Osborne CK; Allred DC; Chang JC
    Breast Cancer Res Treat; 2005 Dec; 94(3):279-84. PubMed ID: 16261403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues.
    Miyoshi Y; Ando A; Takamura Y; Taguchi T; Tamaki Y; Noguchi S
    Int J Cancer; 2002 Jan; 97(1):129-32. PubMed ID: 11774254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells.
    Li Y; Hong X; Hussain M; Sarkar SH; Li R; Sarkar FH
    Mol Cancer Ther; 2005 Mar; 4(3):389-98. PubMed ID: 15767548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients.
    Romero A; Martín M; Oliva B; de la Torre J; Furio V; de la Hoya M; García-Sáenz JA; Moreno A; Román JM; Diaz-Rubio E; Caldés T
    Ann Oncol; 2012 Jul; 23(7):1750-6. PubMed ID: 22052985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot.
    Yoo GH; Piechocki MP; Ensley JF; Nguyen T; Oliver J; Meng H; Kewson D; Shibuya TY; Lonardo F; Tainsky MA
    Clin Cancer Res; 2002 Dec; 8(12):3910-21. PubMed ID: 12473607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of docetaxel resistance genes in castration-resistant prostate cancer.
    Marín-Aguilera M; Codony-Servat J; Kalko SG; Fernández PL; Bermudo R; Buxo E; Ribal MJ; Gascón P; Mellado B
    Mol Cancer Ther; 2012 Feb; 11(2):329-39. PubMed ID: 22027694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of kinesins mediates docetaxel resistance in breast cancer cells.
    De S; Cipriano R; Jackson MW; Stark GR
    Cancer Res; 2009 Oct; 69(20):8035-42. PubMed ID: 19789344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prediction of response to docetaxel in breast cancer].
    Kim SJ; Noguchi S
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):190-3. PubMed ID: 18281755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.